| NDC Code | 0025-1911-31 |
|---|
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0025-1911-31) |
|---|
| Product NDC | 0025-1911 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Calan Sr |
|---|
| Non-Proprietary Name | Verapamil Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 19891215 |
|---|
| End Marketing Date | 20210331 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA019152 |
|---|
| Manufacturer | Pfizer Laboratories Div Pfizer Inc |
|---|
| Substance Name | VERAPAMIL HYDROCHLORIDE |
|---|
| Strength | 180 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
|---|